Yes, CLL (chronic lymphocytic leukemia) is a type of cancer. It is the most common form of leukemia in adults in the United States, accounting for 25 to 30 percent of all leukemia cases. What makes CLL different from many other cancers is that it grows slowly, often takes years to cause problems, and has a five-year survival rate of about 90 percent.
What Kind of Cancer CLL Is
CLL is a blood cancer. It starts in a type of white blood cell called a B lymphocyte, which normally helps your immune system fight infections. In CLL, your bone marrow produces large numbers of these B cells, but they don’t work properly. They look mature under a microscope, but they can’t fight off infections the way healthy B cells can. Over time, these dysfunctional cells accumulate in your blood, bone marrow, lymph nodes, and spleen, crowding out healthy blood cells.
You may also see CLL mentioned alongside something called SLL (small lymphocytic lymphoma). These are the same disease. The difference is simply where the abnormal cells collect: in CLL, they’re found mostly in the blood and bone marrow, while in SLL, they’re found mostly in the lymph nodes. Doctors treat them the same way.
Why CLL Behaves Differently Than Other Cancers
Unlike acute leukemias, which progress rapidly and require immediate treatment, CLL is considered an indolent (slow-growing) cancer. The majority of CLL cells are long-lived but not actively dividing. They resist the normal process of cell death that keeps healthy cell populations in check. Only a small fraction of CLL cells are actively replicating, mostly in the lymph nodes and bone marrow, which is why the disease can remain stable for years.
The pace varies significantly from person to person. In roughly half of patients, the number of abnormal white blood cells doubles over a one-year period. In others, cell counts stay stable for years without any intervention. Transformation into an aggressive acute leukemia happens in fewer than 1 percent of cases.
Symptoms to Recognize
Many people with CLL have no symptoms at all when they’re diagnosed. The disease is often discovered incidentally through routine blood work that shows an unusually high white blood cell count. When symptoms do develop, they typically include:
- Swollen lymph nodes, felt as painless lumps in the neck, armpits, or groin
- Fatigue that doesn’t improve with rest
- Frequent infections
- Drenching night sweats
- Unexplained weight loss
- Pain in the upper left abdomen from an enlarged spleen
- Fever and loss of appetite
Who Gets CLL
CLL is primarily a disease of older adults. The average age at diagnosis is around 70, and about 9 out of 10 people diagnosed are over 50. It’s slightly more common in men than women and more common in White populations. Geographically, it occurs far more frequently in North America and Europe than in Asia.
Family history matters. Having a parent, sibling, or child with CLL raises your risk. Some environmental exposures also play a role: Agent Orange exposure has been linked to higher CLL rates, and long-term contact with certain pesticides may increase risk as well. A precursor condition called monoclonal B-cell lymphocytosis (MBL), where B-cell levels are elevated but not high enough to qualify as CLL, is often considered the earliest step on the path to this cancer.
How CLL Is Diagnosed
Diagnosis requires a sustained count of at least 5,000 abnormal B lymphocytes per microliter of blood, maintained for at least three months. A blood test called flow cytometry confirms the diagnosis by identifying specific protein markers on the surface of these cells. CLL cells carry a distinctive combination of markers that distinguishes them from other blood cancers. The test also confirms that all the abnormal cells are clones of one another, which is the hallmark of a cancer rather than a normal immune response.
How CLL Is Staged
Once diagnosed, CLL is categorized by how far it has progressed. In the United States, doctors typically use the Rai staging system, which ranges from stage 0 through stage III based on blood counts and physical findings. Stage 0 means you have elevated lymphocytes but your lymph nodes, spleen, and liver are normal and your red blood cell and platelet counts are near normal. Higher stages reflect enlarged lymph nodes or organs (stages I and II) or drops in red blood cells indicating the cancer is affecting your bone marrow’s ability to produce healthy cells (stage III).
In Europe, the Binet system is more common. It groups patients into three risk categories (A, B, and C) based on how many areas of lymphoid tissue are enlarged and whether anemia or low platelet counts are present.
Treatment Doesn’t Always Start Right Away
One of the most surprising things for people newly diagnosed with CLL is that treatment often isn’t recommended immediately. The majority of newly diagnosed patients are placed on what doctors call “watch and wait,” meaning regular monitoring without active treatment. This isn’t neglect. Multiple studies have shown that treating early-stage CLL before it causes problems doesn’t improve outcomes.
Treatment typically begins when specific thresholds are crossed: white blood cell counts that double in less than six months, red blood cell or platelet levels that drop consistently below safe levels, lymph nodes that grow larger than 10 centimeters, a significantly enlarged spleen, persistent fevers or night sweats lasting more than two weeks without infection, fatigue severe enough to interfere with daily activities, or unexplained weight loss of 10 percent or more within six months.
Living in watch-and-wait mode can be psychologically difficult. Knowing you have cancer but aren’t being treated for it creates a kind of anxiety that’s well-documented and worth discussing with your care team. The key point is that CLL’s slow growth gives doctors the ability to wait for the right moment to intervene, which often leads to better results than treating too soon.